Count | |
8 | |
3 | |
1 | |
1 | |
4 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
3 | |
1 | |
3 | |
45 | |
3 | |
59 | |
11 | |
3 | |
7 | |
9 | |
35 | |
17 | |
4 | |
8 | |
5 | |
1 | |
2 | |
1 | |
6 | |
17 | |
5 | |
1 | |
1 | |
6 | |
2 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
4 | |
5 | |
5 | |
1 | |
3 | |
3 | |
1 | |
1 | |
6 | |
3 | |
1 | |
4 | |
1 | |
1 | |
1 | |
4 | |
1 | |
4 | |
3 | |
2 | |
1 | |
1 | |
2 | |
4 | |
1 | |
1 | |
1 | |
3 | |
3 | |
1 | |
1 | |
1 | |
Gonadorelin/analogs & derivatives/*metabolism/*therapeutic use | 1 |
1 | |
1 | |
Gonadorelin/*analogs & derivatives/pharmacokinetics/toxicity | 1 |
1 | |
3 | |
Gonadorelin/administration & dosage/secretion/*therapeutic use | 1 |